
Sign up to save your podcasts
Or


Why is it that after decades of cancer research and billions in funding, do we still lack a cure? In this thought-provoking interview, author G. Edward Griffin offers insider perspective on the pharmaceutical industry and its questionable motivations. As the writer of The Creature from Jekyll Island and World Without Cancer, Griffin provides a candid analysis on the disconcerting absence of progress on cancer treatments and how patent incentives have obstructed advances against this disease. Griffin presents an unsettling case that healing is not the overriding priority. This is a sober invitation to reconsider whether today’s health institutions truly serve the public good over economic gain.
or Call 866-349-3310
👋 STAY IN TOUCH WITH US ⬇️
🟩 Schedule a Strategy Session: 866-349-3310
🟩 Email us at [email protected]
🟩 Official Homepage http://www.itmtrading.com
🟩 ITM Trading Twitter: https://twitter.com/itmtrading
🟩 Facebook: https://facebook.com/ITMTrading
By The Daniela Cambone Show and Taylor Made Economics4.8
6060 ratings
Why is it that after decades of cancer research and billions in funding, do we still lack a cure? In this thought-provoking interview, author G. Edward Griffin offers insider perspective on the pharmaceutical industry and its questionable motivations. As the writer of The Creature from Jekyll Island and World Without Cancer, Griffin provides a candid analysis on the disconcerting absence of progress on cancer treatments and how patent incentives have obstructed advances against this disease. Griffin presents an unsettling case that healing is not the overriding priority. This is a sober invitation to reconsider whether today’s health institutions truly serve the public good over economic gain.
or Call 866-349-3310
👋 STAY IN TOUCH WITH US ⬇️
🟩 Schedule a Strategy Session: 866-349-3310
🟩 Email us at [email protected]
🟩 Official Homepage http://www.itmtrading.com
🟩 ITM Trading Twitter: https://twitter.com/itmtrading
🟩 Facebook: https://facebook.com/ITMTrading

5,689 Listeners

578 Listeners

149 Listeners

316 Listeners

262 Listeners

370 Listeners

256 Listeners

1,032 Listeners

469 Listeners

113 Listeners

374 Listeners

72 Listeners

415 Listeners

69 Listeners

46 Listeners